MRI viability imaging for cardiomyopathies

Prabhakar Rajiah, Scott D. Flamm

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

MRI plays an important role in managing patients with cardiomyopathy by determining the presence or extent of ischemic scar or interstitial fibrosis using viability imaging. Delayed Enhancement MRI is an excellent technique for accurate, reproducible detection and quantification of myocardial scar. Cardiac MRI with delayed enhancement is also useful in the differentiation of ischemic from nonischemic cardiomyopathies and in the characterization of various nonischemic cardiomyopathies. The presence of scar/interstitial fibrosis is a substrate for arrhythmia and increases the risk of adverse cardiovascular events, making DE-MRI an important tool for prognosis.

Original languageEnglish (US)
Pages (from-to)33-47
Number of pages15
JournalApplied Radiology
Volume38
Issue number11
StatePublished - Nov 1 2009

Fingerprint

Cardiomyopathies
Cicatrix
Fibrosis
Cardiac Arrhythmias

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Rajiah, P., & Flamm, S. D. (2009). MRI viability imaging for cardiomyopathies. Applied Radiology, 38(11), 33-47.

MRI viability imaging for cardiomyopathies. / Rajiah, Prabhakar; Flamm, Scott D.

In: Applied Radiology, Vol. 38, No. 11, 01.11.2009, p. 33-47.

Research output: Contribution to journalReview article

Rajiah, P & Flamm, SD 2009, 'MRI viability imaging for cardiomyopathies', Applied Radiology, vol. 38, no. 11, pp. 33-47.
Rajiah P, Flamm SD. MRI viability imaging for cardiomyopathies. Applied Radiology. 2009 Nov 1;38(11):33-47.
Rajiah, Prabhakar ; Flamm, Scott D. / MRI viability imaging for cardiomyopathies. In: Applied Radiology. 2009 ; Vol. 38, No. 11. pp. 33-47.
@article{6d0e654a67154b91812b360c4507dda8,
title = "MRI viability imaging for cardiomyopathies",
abstract = "MRI plays an important role in managing patients with cardiomyopathy by determining the presence or extent of ischemic scar or interstitial fibrosis using viability imaging. Delayed Enhancement MRI is an excellent technique for accurate, reproducible detection and quantification of myocardial scar. Cardiac MRI with delayed enhancement is also useful in the differentiation of ischemic from nonischemic cardiomyopathies and in the characterization of various nonischemic cardiomyopathies. The presence of scar/interstitial fibrosis is a substrate for arrhythmia and increases the risk of adverse cardiovascular events, making DE-MRI an important tool for prognosis.",
author = "Prabhakar Rajiah and Flamm, {Scott D.}",
year = "2009",
month = "11",
day = "1",
language = "English (US)",
volume = "38",
pages = "33--47",
journal = "Applied Radiology",
issn = "0160-9963",
publisher = "Anderson Publishing Ltd",
number = "11",

}

TY - JOUR

T1 - MRI viability imaging for cardiomyopathies

AU - Rajiah, Prabhakar

AU - Flamm, Scott D.

PY - 2009/11/1

Y1 - 2009/11/1

N2 - MRI plays an important role in managing patients with cardiomyopathy by determining the presence or extent of ischemic scar or interstitial fibrosis using viability imaging. Delayed Enhancement MRI is an excellent technique for accurate, reproducible detection and quantification of myocardial scar. Cardiac MRI with delayed enhancement is also useful in the differentiation of ischemic from nonischemic cardiomyopathies and in the characterization of various nonischemic cardiomyopathies. The presence of scar/interstitial fibrosis is a substrate for arrhythmia and increases the risk of adverse cardiovascular events, making DE-MRI an important tool for prognosis.

AB - MRI plays an important role in managing patients with cardiomyopathy by determining the presence or extent of ischemic scar or interstitial fibrosis using viability imaging. Delayed Enhancement MRI is an excellent technique for accurate, reproducible detection and quantification of myocardial scar. Cardiac MRI with delayed enhancement is also useful in the differentiation of ischemic from nonischemic cardiomyopathies and in the characterization of various nonischemic cardiomyopathies. The presence of scar/interstitial fibrosis is a substrate for arrhythmia and increases the risk of adverse cardiovascular events, making DE-MRI an important tool for prognosis.

UR - http://www.scopus.com/inward/record.url?scp=71149116516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71149116516&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:71149116516

VL - 38

SP - 33

EP - 47

JO - Applied Radiology

JF - Applied Radiology

SN - 0160-9963

IS - 11

ER -